Delivery Order SPE2DB22D2007-SPE2DB24FJ1BV
Award Date 4/1/24
Potential Completion Date 4/22/24
Potential Value $7.1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $9,722.10 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of 4,564,743,440 units of the pharmaceutical product GAMUNEX-C 10 GRAM/100 ML VIAL 100ML, with a completion date of June 20, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which allows the...
- The U.S. Defense Logistics Agency (DLA) awarded a $24,045.40 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4,564,437,707 units of the pharmaceutical product GAMUNEX-C 40 GRAM/400 ML VIAL 400ML. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,253.45, is for the supply of 4,567,958,190 units of the pharmaceutical product GAMUNEX-C 20 GRAM/200 ML VIAL 200ML. The contract has an ultimate completion date of May 8, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. This delivery order is part of a...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $57,708.96 to AmerisourceBergen Drug Corp for the supply of 40-gram/400-mL vials of the pharmaceutical product GAMUNEX-C. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between the DLA and AmerisourceBergen for the delivery of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a delivery order contract worth $49,752.80 for the supply of GAMUNEX-C 40 gram/400 ml vials. The contract has a firm fixed price and an ultimate completion date of January 6, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product GAMUNEX-C 40 GRAM/400 ML VIAL 400ML. The contract is a firm fixed price award with a potential value of $48,090.80 and a completion date of March 28, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GAMUNEX-C 5 gram/50 mL vials. The contract has a ceiling value of $3,036.70 and a period of performance through July 15, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $28,854.48 firm-fixed-price delivery order is for the supply of 4,564,994,414 units of the pharmaceutical product GAMUNEX-C 40 gram/400 mL vial, with a completion date of July 17, 2024. AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a $999,999,999.00 Indefinite Delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,220.94, is for the supply of GAMUNEX-C 10 GRAM/100 ML VIAL 100ML, a medical product. The contract has an ultimate completion date of April 1, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distributor, to supply GAMUNEX-C 10 gram/100 ml vials. The $7,213.68 contract has an ultimate completion date of April 24, 2024 and does not utilize a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...